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ABSTRAK 
Ketoksikan sistematik bius lokal (KSBL) adalah satu kejadian yang jarang berlaku 
tetapi boleh mengancam nyawa dan terjadi selepas suntikan blok pada saraf 
periferal. Kejadian ini mungkin berpunca dari pelbagai faktor termasuk pilihan 
ubat, teknik pemberian ubat atau faktor risiko pesakit sendiri. Kami melaporkan 
satu kes seorang wanita berusia 55 tahun yang menghidap pening kepala, 
percakapan telor dan lumpuh kesemua tangan dan kaki selepas beliau menerima 
suntikan campuran ubat lignocaine dan hidrokortison pada sendi di bahu kanan. 
Pemeriksaan neurologi menunjukkan ton otot lemah dan skala kekuatan otot kaki 
dan tangan 0/5. Kejadian-kejadian toksik ini mungkin disebabkan oleh suntikan 
yang tidak disengajakan ke dalam salur darah arteri atau lapisan dura pada saraf 
atau penyerapan ubat dari tisu berdekatan. Laporan kes ini menceritakan tentang 
suntikan ke dalam sendi bahu yang boleh menyebabkan KSBL yang mungkin tidak 
dikenalpasti kerana ia boleh menyerupai strok.     
Kata kunci: bius lokal, dalam sendi, lidocaine, sendi bahu, strok, suntikan
ABSTRACT
Local anaesthesia systemic toxicity (LAST) is an uncommon and a potentially 
life-threatening event that develops after peripheral nerve block. The cause 
may be multifactorial and may include the choice of drug, technique of block 
and individual patient risk factors. We report a case of a 55-year-old female 
who developed slurring of speech and quadriplegia after receiving a mixture of 
lignocaine and hydrocortisone through an intra-articular injection to the right 
shoulder. Neurological examination revealed hypotonia and absence of power (0/5) 
in all limbs. These toxic events may have resulted from an accidental intra-arterial 
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or dural cuff injection of local anaesthesia or absorption from surrounding tissues. 
This case report demonstrated that an intra-articular injection in the shoulder may 
cause LAST and may be under-recognized as it can mimic stroke.
Keywords: intra-articular, injection, lidocaine, local anaesthesia, shoulder joint, 
stroke
her supraspinatus tendinopathy at the 
Orthopaedic Clinic. Her body weight 
was 60kg. The physician confirmed 
that no blood was aspirated prior 
to anaesthetic injection. On further 
history, she had no previous history of 
allergy to drugs and food. In ED, her 
blood pressure was 144/80 mmHg, 
heart rate was 69 beats/minute and 
respiratory rate was 20 breaths/minute, 
saturation in room air was 99% and 
temperature was 37oC. 
 On clinical examination, she was 
alert. Her speech was significantly 
slurred and she was unable to open 
both eyes and mouth. Both pupils 
were normal and reactive to light. 
Neurological examination revealed 
hypotonia, power of 0/5 and normal 
reflexes for all four limbs. The extensor 
plantar responses were normal and 
no clonus noted. The Hoover’s test 
was not performed. Cranial nerve 
examination and other components 
of neurological assessment were 
unremarkable. Cardiorespiratory 
function was intact. There was no 
documented hypoxia. An urgent head 
computed tomography scan & spine 
magnetic resonance imaging showed 
no abnormality. The nerve conduction 
study was also insignificant. She 
was admitted for supportive care 
which included rehabilitation and 
INTRODUCTION
Lignocaine is the most frequently 
used drug in almost all medical 
specialties especially in the Emergency 
Department (ED) (Torp & Simon 2018). 
Local anaesthesia systemic toxicity 
(LAST) is a potentially life-threatening 
event that may develop following 
peripheral nerve block using lignocaine 
(Barrington & Kluger 2013). The cause 
may be multifactorial and may include 
the choice of drug, technique of block 
and individual patient risk factors. The 
existing guideline on LAST was written 
based on animal and human studies 
and case reports (Neal et al. 2010). 
The present case report highlights an 
interesting case of LAST mimicking 
an acute stroke after an intra-articular 
lignocaine injection which has not 
been reported, to date. 
CASE REPORT 
A 55-year-old lady presented to the ED 
with dizziness, numbness of tongue 
and mouth, progressively developing 
slurring of speech and quadriplegia. 
The symptoms began to develop 
ten minutes after she had an intra-
articular injection to the right shoulder 
containing a mixture of 200mg 2% 
lignocaine and 1ml hydrocortisone for 
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neurological monitoring. Serum level 
of lignocaine test was not done. Her 
slurred speech was resolved after six 
hours and the neurological function 
regained full recovery of over a period 
of nine days.  
DISCUSSION 
LAST is suspected when a patient 
develops abnormal neurological and 
cardiovascular symptoms or when 
cardiac arrest ensues following a local 
anaesthetic (LA) agent administration. 
The incidence of LAST for peripheral 
nerve block is rare and reported in 
only nearly 10/10,000 patients in 
2009 (Christie et al. 2014). Lignocaine 
toxicity can occur up to 1 in 2000 for 
peripheral nerve block, depending on 
the type of block (Torp & Simon 2018). 
To date, intra-articular injection was 
not reported to cause LAST. 
 Besides classic neurological 
complication of LAST such as circumoral 
numbness and seizure, unusual 
CNS presentations were discussed. 
Despite careful drug dosage, isolated 
unresponsiveness without respiratory 
and hemodynamic depression has 
been reported after dental surgery 
using lignocaine (Hayaran et al. 
2017). In this case, a mixture of 
2% lignocaine and adrenaline was 
infiltrated into the inner surface of the 
lower lip and vestibule. Several cases 
of transient locked-in syndrome were 
reported following stellate ganglion 
block where the patients remained 
conscious and able to blink their eyes 
despite being quadriplegic and having 
respiratory depression (Chaturvedi & 
Dash 2010). Accidental intra-arterial 
injection and absorption from the 
surrounding tissues were thought to 
cause CNS toxicity.  In the present 
case, the patient demonstrated 
transient locked-in syndrome with 
stable cardiorespiratory function after 
administration of lignocaine into the 
right shoulder. A rapid central neural 
blockade may happen during the 
intra-articular shoulder injection. 
It may be due to an inadvertent 
injection of local anaesthetic in the 
dural cuff which travels retrogradely 
into the subepineural space and 
subsequently into C4 to T8 spinal 
cord levels. Prolonged block in this 
patient was likely due to slow spread 
of drug through epidural fat into the 
intradural space (Arcas-Bellas et al. 
2009; Finucane & Tsui 2007). Given 
the absence of any objective findings 
to explain the patient’s neurological 
deficit, one should consider functional 
disorder such as conversion disorder. 
Functional magnetic resonance 
imaging identifies abnormal brain 
activity during patient’s examination 
(Smith  et al. 2007). Other differentials 
were high cervical cord injury and 
pontine stroke.
 The cornerstone of the treatment 
for LAST is to prompt an effective 
airway management (Christie et al. 
2014; Neal et al. 2010). In the present 
case, the patient was stable throughout 
admission without ventilation support. 
Lipid emulsion may be considered in 
the event of arrhythmia, prolonged 
seizure or progressive toxicity. It 
restores cardiac contractility by 
withdrawing the lipid content in 
lignocaine. Nonetheless, Hayaran et 
al. (2017) administered lipid emulsion 
269
Local Anesthesia Toxicity Med & Health Jun 2019;14(1): 266-269
in an unconscious patient without 
cardiac compromise. This differs from 
Chaturvedi and Dash (2010) when 
they resuscitated a hemodynamically 
unstable patient according to ACLS 
protocol without lipid emulsion 
institution. This did not happen in 
our case as lipid emulsion was not 
favoured in view of a stable cardiac 
status. We believed that the patient 
suffered from acute central neural 
blockade following LA injection into 
the shoulder joint. Lack of experience 
and no diagnostic test to confirm the 
diagnosis left us perplexed. There was 
not enough evidence to determine if 
early lipid emulsion administration 
can halt the progress of the disease or 
shorten duration of symptoms.   
 CONCLUSION
The present case illustrated a rare 
manifestation of LAST after an intra-
articular injection in the shoulder. The 
diagnosis is challenging. Thus, early 
recognition of clinical symptoms as 
well as prompt treatment, is essential to 
prevent the progression of the disease.
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